Drug Shortage Report for AURO-TOPIRAMATE
Report ID | 124156 |
Drug Identification Number | 02345846 |
Brand name | AURO-TOPIRAMATE |
Common or Proper name | Topiramate |
Company Name | AURO PHARMA INC |
Market Status | MARKETED |
Active Ingredient(s) | TOPIRAMATE |
Strength(s) | 200MG |
Dosage form(s) | TABLET |
Route of administration | ORAL ORAL |
Packaging size | 100 |
ATC code | N03AX |
ATC description | ANTIEPILEPTICS |
Reason for shortage | Demand increase for the drug. |
Anticipated start date | |
Actual start date | 2020-09-11 |
Estimated end date | |
Actual end date | 2021-01-26 |
Shortage status | Resolved |
Updated date | 2021-01-29 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 3700 STEELES AVENUE WEST, SUITE 402 WOODBRIDGE, ONTARIO CANADA L4L 8K8 |
Company contact information | Balaji Srinivasan |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v11 | 2021-01-29 | French | Compare |
v10 | 2021-01-29 | English | Compare |
v9 | 2020-12-07 | French | Compare |
v8 | 2020-12-07 | English | Compare |
v7 | 2020-11-24 | French | Compare |
v6 | 2020-11-24 | English | Compare |
v5 | 2020-09-29 | French | Compare |
v4 | 2020-09-29 | English | Compare |
v3 | 2020-09-12 | English | Compare |
v2 | 2020-09-11 | French | Compare |
v1 | 2020-09-11 | English | Compare |
Showing 1 to 11 of 11